Safety Information Thyrogen® (thyrotropin alfa for injection) is indicated for use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine whole-body scan (WBS) in the follow-up of patients with well-differentiated thyroid cancer. It is a prescription product injected into the muscle. Thyrogen® may not be appropriate for all patients. The most commonly reported adverse events are headache, nausea, weakness and vomiting. Even with a Thyrogen®-stimulated Tg testing and WBS, a risk remains of missing a diagnosis of thyroid cancer or of underestimating the extent of disease. Adverse events should be reported promptly to Genzyme Medical Information at 1-800-745-4447. For more information on Thyrogen®, please see
full prescribing information (PDF), contact the Medical Information department or contact Genzyme
toll free at 1-88-THYROGEN (1-888-497-6436).
Search Thyrogen
Highlight
Take Action Early
Promote early detection and treatment and long-term monitoring among your colleagues. Educate your patients about the resources and support available to them.